Taken together, these results suggest that CCL2/5 can originate from noncancerous cells such as macrophages in the ovarian cancer microenvironment, as well as tumor cells, and may play a role in ovarian cancer progression and chemoresistance. The gene discussed is CCL2; the disease is ovarian carcinoma.